Avner Schneur led several companies from early-stage to IPO or other exits.
Avner Schneur is currently President and CEO of GRM Document Management www.grmdocumentmanagement.com. Under Schneur's leadership, GRM accelerated its growth expanded to the Digital area and geographically to South America.
Avner is also the President and CEO of VisualVault https://www.visualvault.com a leading ECM and CSP provider.
In 2011 Schneur founded and serves as the CEO of Kormeli, LLC www.kormeli.com an investment Group dedicated to funding and guiding early-stage technology entrepreneurs and enterprises. Kormeli has about 35 investments in various companies and had successful exits selling InfinitMD to ConsumerMedical https://www.alight.com and TrueClinic to InTouch Health / Teladoc (TDOC) https://www.teladoc.com/.
Schneur is a member of the Technion Industrial Engineering Faculty Advisory Board.
In late 1999 Schneur founded Emptoris Inc, a leading Supply and Contract mgt Software Company, and served as the company’s Chairman, President, and CEO. ֵSchneur’s goal was to transform the way companies procure goods and services utilizing mathematical optimization technology. The company’s novel approach involved taking a broader look at the total cost of significant procurements, ultimately enabling substantial savings for customers. IBM acquired Emptoris in 2011. Before founding, Emptoris Schneur held several executive positions at Vectis Corporation, a leading software vendor of electronic medical records. Astea International, a leading developer of customer interaction software, Schneur helped lead the company to a successful IPO. Elscint, Inc., a manufacturer of high-end medical imaging systems.
Schneur Graduated Cum Laude in Industrial Engineering, with a specialty in Information Systems, from the Technion (Israel Institute of Technology).
Schneur and his wife Rina established The Rina and Avner Schneur Center of Type II Diabetes Research. The center brings together top researchers from the faculty of Biomedical Engineering and the faculty of Medicine at the Technion Israel Institute of Technology to seek a cure to type II diabetes. https://schneur-diabetic-center.net.technion.ac.il/